Cancer Biomarkers

ROCHESTER, MINNESOTA & PHOENIX, ARIZONA | January 22, 2026 — The Advanced Clinical Trials and Translational Sciences Research Program...

Dallas, Texas, October 30, 2025 — Lantern Pharma Inc. (NASDAQ: LTRN) announced it will present two cutting-edge AI-driven drug-development...

Foresight Diagnostics, a leader in ultrasensitive minimal residual disease (MRD) detection, presented new clinical performance data on its Foresight...